Catalase.

Copper-zinc superoxide dismutase converts superoxide into hydrogen peroxide, and catalase breaks that peroxide down into water and oxygen. The second enzyme clears exactly what the first one produces, and zinc is a structural cofactor of the first.

Glutathione peroxidase is a selenoenzyme that removes hydrogen peroxide alongside catalase, working at lower peroxide concentrations while catalase handles the higher ones. Selenium status sets how much of that parallel capacity exists.

Catalase is a heme enzyme with four iron-porphyrin groups at its active sites. Without adequate iron the body cannot assemble functional catalase, whatever the enzyme protein level.

NAC supplies cysteine for glutathione, the reducing substrate glutathione peroxidase spends when it clears peroxide. Keeping that pool topped up leaves catalase handling the larger peroxide loads rather than all of them.

Catalase breaks hydrogen peroxide into water and oxygen at high peroxide concentrations, while glutathione peroxidase clears the same molecule at low concentrations using reduced glutathione. The two cover different parts of the same range.

Copper and zinc are the metals in cytosolic superoxide dismutase, which converts superoxide into hydrogen peroxide. That peroxide is the substrate catalase then decomposes, making the two consecutive steps.

Manganese is the metal in the mitochondrial form of superoxide dismutase, which generates hydrogen peroxide inside the organelle. Catalase and the glutathione route then clear that peroxide, so the pathway needs both ends staffed.

Riboflavin becomes FAD, the cofactor glutathione reductase needs to regenerate reduced glutathione. Without it the peroxidase arm stalls and more of the peroxide load falls to catalase.

Niacin builds the NADP pool, and NADPH both holds catalase in its active conformation and drives glutathione reductase. The reducing power behind peroxide clearance traces back to this vitamin.

Dihydrolipoate regenerates glutathione and other thiols, keeping the peroxidase route supplied while catalase handles the higher-concentration peroxide. Two complementary parts of one clearance network.

Catalase works on water-soluble hydrogen peroxide, while tocopherol stops chain reactions among lipid peroxides inside membranes. Neither reaches the other's compartment, which is why both appear in antioxidant formulas.

Ascorbate scavenges aqueous radicals and regenerates tocopherol, and its own oxidation in the presence of transition metals produces hydrogen peroxide. Catalase clears that peroxide, so the two are linked in both directions.

Catalase is a large heme protein, and gastric pepsin at low pH hydrolyses it into inactive fragments. An oral catalase needs enteric protection, so putting it in the same capsule as pepsin or an acid source works against it.

Superoxide dismutase converts superoxide into hydrogen peroxide, and hydrogen peroxide is catalase's only substrate. The two enzymes are sequential steps in one detoxification route, so SOD activity without a peroxide-removing enzyme simply moves the oxidant along. This is settled enzymology and needs no trial to state.

Ubiquinol is a lipid-phase antioxidant that intercepts radicals inside membranes, territory catalase cannot reach because catalase works on hydrogen peroxide in the aqueous phase and in peroxisomes. The two cover different compartments of the same defence problem. Compartment complementarity is mechanistic reasoning, not a measured combined effect.

Astaxanthin sits across the lipid bilayer and quenches singlet oxygen and lipid radicals without becoming a pro-oxidant as readily as some carotenoids. Catalase handles the aqueous peroxide arm. Different compartments, one system, and no joint human measurement offered here.

Quercetin scavenges radicals and also chelates transition metals, which matters because free iron and copper drive Fenton chemistry that turns hydrogen peroxide into the far more damaging hydroxyl radical. Removing the catalyst and removing the substrate are complementary. The chemistry is in vitro and the human relevance is not established from it.

Sulforaphane modifies cysteine residues on KEAP1, which frees Nrf2 to enter the nucleus and increase transcription of antioxidant response element genes, catalase among the enzymes reported to rise. That means the body makes more of its own catalase rather than absorbing supplied enzyme. Induction of an enzyme is a marker-level change, not an outcome.

Broccoli sprouts carry glucoraphanin, which myrosinase from the plant or from gut bacteria converts to sulforaphane, the Nrf2 activator. Endogenous catalase expression is among the antioxidant enzymes reported to increase. Conversion efficiency depends on whether active myrosinase survived processing, which is a real formulation variable.

Curcuminoids are reported to activate Nrf2 signalling and raise antioxidant enzyme activities including catalase in cell and animal models. Enzyme activity is a marker measured in tissue or blood, not a clinical endpoint. Curcumin's own low oral bioavailability limits how much of the cell-culture picture carries over.

EGCG scavenges radicals, but in cell culture it also autoxidises and generates hydrogen peroxide in the medium, which catalase then removes. That is why catalase is routinely added to catechin experiments as a control. The interaction is real chemistry and its direction in a person is not settled.

Resveratrol has been reported to raise catalase and superoxide dismutase activities in animal and cell models, largely through Nrf2 and sirtuin signalling. These are enzyme activity markers in tissue, not clinical results. Human oral exposure to unconjugated resveratrol is low, which limits translation.

Melatonin is reported to increase catalase and glutathione peroxidase activities in animal tissue and to scavenge radicals directly. Those are activity measurements in tissue rather than clinical outcomes. Melatonin also has its own timing effects on sleep and should not be added to a formula purely as an antioxidant.

Taurine reacts with hypochlorous acid to form the more stable taurine chloramine, damping a reactive chlorine species produced downstream of hydrogen peroxide by myeloperoxidase. Catalase removes the peroxide before that step. The two intervene at consecutive points in the same chemistry.

Nicotinamide riboside enters the NAD salvage pathway through nicotinamide riboside kinase, feeding the NAD pool that is phosphorylated to NADP and reduced to NADPH. NADPH is the cofactor that keeps catalase from being trapped in its inactive intermediate. Raising a precursor pool is not the same as raising enzyme activity, and the distinction belongs on the label.

Nicotinamide mononucleotide is the immediate precursor of NAD in the salvage route, upstream of the NADPH that stabilises catalase against compound II formation. The biochemical link is settled. How much oral NMN reaches a given tissue's NADPH pool is a separate and contested question.

Tocotrienols terminate lipid peroxidation chains within membranes, the reaction catalase cannot touch because its substrate is aqueous hydrogen peroxide. Lipid-phase and aqueous-phase coverage together is the standard antioxidant formulation logic. Complementary chemistry, not a demonstrated joint effect.

Proanthocyanidins scavenge radicals and bind transition metals, which limits the Fenton reaction that converts hydrogen peroxide into hydroxyl radical. Catalase removes the peroxide substrate itself. Both are in vitro descriptions of the same problem approached from either end.

Pine bark procyanidins scavenge radicals and are reported to influence endogenous antioxidant enzyme activities in laboratory work. Any catalase activity change reported in such studies is a marker in blood or tissue. Direction and size in people are not established from that work.

Lactoferrin binds ferric iron tightly, and free iron is the catalyst that turns hydrogen peroxide into hydroxyl radical. Sequestering the catalyst reduces the damage a given peroxide load can do, while catalase reduces the load. One removes the fuel, the other removes the spark.

Catalase is a protein of about 240 kilodaltons, and pancreatin supplies trypsin, chymotrypsin and elastase, which hydrolyse dietary protein in the small intestine. Co-dosing a broad protease blend with an orally supplied enzyme works against the enzyme surviving intact. Separating them in time, or coating the enzyme, is the ordinary answer.

Any protease-containing enzyme blend acts on catalase as it acts on other dietary protein. This is not a subtle interaction, it is the same chemistry that digests a steak. It is worth stating because supplement formulas often place enzyme ingredients side by side without noting it.

Betaine hydrochloride lowers gastric pH, and catalase loses its tertiary structure and heme environment at strongly acidic pH. Deliberately acidifying the stomach therefore works against an uncoated oral enzyme. Which is why enzyme products intended to reach the intestine are enteric coated.

Bicarbonate neutralises stomach acid and briefly raises gastric pH, a less denaturing environment for an acid-labile protein. The buffering window is short and does not substitute for an enteric coating. Stated as a formulation consideration rather than a benefit.